HER2-Positive Metastatic Breast Cancer: New Therapies

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Minetta C. Liu, MD

Professor and Research Chair, Division of Medical Oncology, Department of Oncology, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Medical Director, Office of Specialty Collaborations and Contracts, Co-Leader, Genomics in Action Strategic Priority, Center for Individualized Medicine, Mayo Clinic

Sara A. Hurvitz, MD, FACP

Professor of Medicine, Director, Breast Cancer Clinical Trials Program, Division of Hematology-Oncology, David Geffen School of Medicine, UCLA, Medical Director, Clinical Research Unit, Jonsson Comprehensive Cancer Center

Jennifer M. Matro, MD

Associate Clinical Professor of Medicine, Division of Hematology/Oncology, University of California San Diego Health

Lauren Chatalian, MSW

Women & Children’s Program Manager, CancerCare